Veronica Salib Associate Editor, Xtelligent/TechTarget xtelligent Pharma Life Sciences The Complexities of Chronic Kidney Disease and Its Stages 18 Jul 2022 xtelligent Pharma Life Sciences White House Announces Plans to Manage Omicron Subvariant BA.5 15 Jul 2022 xtelligent Pharma Life Sciences Decentralization Tools May Improve Cancer Clinical Trial Enrollment 15 Jul 2022 xtelligent Pharma Life Sciences HHS Issues Pharmacies’ Obligation to Ensure Access to Reproductive Care 15 Jul 2022 xtelligent Pharma Life Sciences Patient–Physician Language Agreement Improves Patient Outcomes 13 Jul 2022 xtelligent Pharma Life Sciences Psychotropic Medications Linked to an Increased Risk of Parkinson’s 13 Jul 2022 xtelligent Pharma Life Sciences HRA Pharma Submits FDA Application for First OTC Birth Control Pill 12 Jul 2022 xtelligent Pharma Life Sciences AI Smartphone App Assists in Assessing Stool Form 12 Jul 2022 xtelligent Pharma Life Sciences PTSD Is Associated with Accelerated Cognitive Decline 11 Jul 2022 xtelligent Pharma Life Sciences Decibel Therapeutics Announces Results of DB-020 Clinical Trial 11 Jul 2022 xtelligent Pharma Life Sciences Understanding the Multifaceted Aspects of Dementia, Its Stages, Subtypes 11 Jul 2022 xtelligent Pharma Life Sciences Revolutions in Neuroscience: Deep Brain Stimulation 11 Jul 2022 xtelligent Pharma Life Sciences FDA Expands EUA to Allow Pharmacists to Prescribe Paxlovid 08 Jul 2022 xtelligent Pharma Life Sciences Telemedicine Can Improve Likelihood of Obtaining Mental Health Services 08 Jul 2022 xtelligent Pharma Life Sciences Infertility May Correlate with Risk of Stroke in Women 07 Jul 2022 xtelligent Pharma Life Sciences FDA Releases Drug Safety Communication regarding Cancer Drug, Copiktra 07 Jul 2022 xtelligent Pharma Life Sciences FDA Approves New Treatment for Large B-Cell Lymphoma 06 Jul 2022 xtelligent Pharma Life Sciences Australia Announces First Diphtheria Cases in Several Decades 06 Jul 2022 xtelligent Pharma Life Sciences FDA Approves New Weight Management Drug for Kids over 12 05 Jul 2022 xtelligent Pharma Life Sciences Reduced Muscle Strength Is Associated with a Higher Risk of Dementia 05 Jul 2022 xtelligent Pharma Life Sciences HPV Vaccine Rates Increase among Adolescents 01 Jul 2022 xtelligent Pharma Life Sciences Study Finds Sex Differences in Long COVID and COVID Sequelae 01 Jul 2022 xtelligent Pharma Life Sciences Radiologists Look for Ways to Conserve amidst the Dye Shortage 30 Jun 2022 xtelligent Pharma Life Sciences HHS Secretary Announces Plan to Provide Abortion Care 29 Jun 2022 xtelligent Pharma Life Sciences Women Are Underrepresented in Clinical Trials, Leading to Health Inequity 29 Jun 2022 xtelligent Pharma Life Sciences USPTF Updates Recommendations on Supplements to Prevent Cancer 28 Jun 2022 xtelligent Pharma Life Sciences Smartphone Apps’ Impact on the COVID Pandemic 28 Jun 2022 xtelligent Pharma Life Sciences Risk of Late Non-Small Cell Lung Cancer Impacted by Income and Education 27 Jun 2022 xtelligent Pharma Life Sciences Epilepsy Drug Prices Have Increased by 277% in the Past Decade 27 Jun 2022 xtelligent Pharma Life Sciences FDA Expanded Approval of Skyrizi for Treatment of Crohn’s Disease 24 Jun 2022 xtelligent Pharma Life Sciences PCOS Patients at Higher Risk of Delivery-Related Heart Complications 24 Jun 2022 xtelligent Pharma Life Sciences Vagus Nerve Stimulation Augments Behaviors in Epilepsy Patients 23 Jun 2022 xtelligent Pharma Life Sciences Virtual Cognitive Behavioral Therapy Effective in PTSD Patients 23 Jun 2022 xtelligent Pharma Life Sciences Reduced Risk of Long COVID with Omicron versus Delta Variant 22 Jun 2022 xtelligent Pharma Life Sciences FDA Approved Weight-Management Treatment for Bardet–Biedl Syndrome 22 Jun 2022 xtelligent Pharma Life Sciences Beta Bionics Shares Clinical Trial Data on Bionic Pancreas for Type 1 Diabetes 21 Jun 2022 xtelligent Pharma Life Sciences CRISPR Treatment in Clinical Trial for Pediatric Sickle Cell Disease 21 Jun 2022 xtelligent Pharma Life Sciences AHN Announces Clinical Study Using DBS to Treat Opioid Addiction 20 Jun 2022 xtelligent Pharma Life Sciences Could the Approval of Albrioza by Health Canada for ALS Impact the FDA Ruling? 20 Jun 2022 xtelligent Pharma Life Sciences Climate Change Contributes to Rising Rates of Lyme Disease 17 Jun 2022 xtelligent Pharma Life Sciences FDA Advisory Board Unanimously Votes to Approve Pfizer COVID Vaccine for Kids under 5 17 Jun 2022 xtelligent Pharma Life Sciences AMA Urges FDA to Make Oral Contraceptives Available Over the Counter 16 Jun 2022 xtelligent Pharma Life Sciences Olumiant Becomes the First FDA-Approved Systemic Treatment for Alopecia Areata 15 Jun 2022 xtelligent Pharma Life Sciences AMA Policy Changes Identify Climate Change as Public Health Crisis 15 Jun 2022 1 2 3 4 5 6 7 8 9 10 11
